New COVID vaccine formulas tested for better protection
NCT ID NCT07089706
Summary
This study is testing updated versions of Moderna's COVID-19 vaccine designed to match current virus variants. It will enroll about 832 people aged 65 and older, or those 12-64 with health conditions that put them at high risk for severe COVID-19. The main goals are to see how well the new vaccine formulas trigger an immune response and to monitor their safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
DelRicht Research-Atlanta
RECRUITINGAtlanta, Georgia, 30329, United States
-
DelRicht Research-Baton Rouge
RECRUITINGBaton Rouge, Louisiana, 70769, United States
-
DelRicht Research-Gulfport
RECRUITINGGulfport, Mississippi, 39503, United States
-
DelRicht Research-New Orleans
RECRUITINGNew Orleans, Louisiana, 70115, United States
-
DelRicht Research-Tulsa
RECRUITINGTulsa, Oklahoma, 74133, United States
Conditions
Explore the condition pages connected to this study.